" "@en . . . . . . . . . . . . . . . . . . . . . . . . . "9alpha-FLUOROCORTISOL"@en . . "Humans and other mammals"@en . "U.S. Patent 2,957,013"@en . . . . "127-31-1"@en . . . "Fludrocortison"@en . . . . . . . "Take with food to reduce irritation."@en . . . . "Fludrocortisone binds the mineralocorticoid receptor (aldosterone receptor). This binding (or activation of the mineralocorticoid receptor by fludrocortisone) in turn causes an increase in ion and water transport and thus raises extracellular fluid volume and blood pressure and lowers potassium levels."@en . . . . "Fludrocortisona"@en . "approved"@en . . . . "Fludrocortisone"@en . . . . "For partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenogenital syndrome."@en . . . . " "@en . "3.5 hours"@en . "High"@en . "Avoid excess salt/sodium unless otherwise instructed by your physician."@en . "Fludrocortisonum"@en . . . . . . "A synthetic mineralocorticoid with anti-inflammatory activity. [PubChem]"@en . . . . . . . . . . . . . "Effects of overexposure include irritation, cardiac edema, increased blood volume, hypertension, cardiac arrhythmias, enlargement of the heart, headaches, and weakness of the extremities."@en . . . "Fludrocortisone"@en . . "Fluohydrocortisone"@en .